Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ali El-Ali"'
Autor:
Jong Wook Lee, Sung-Soo Yoon, Zhi Xiang Shen, Arnold Ganser, Hui-Chi Hsu, Ali El-Ali, Dany Habr, Nicolas Martin, John B. Porter
Publikováno v:
Haematologica, Vol 98, Iss 7 (2013)
Reports are emerging of hematologic responses associated with iron chelation therapy; however, studies are limited in aplastic anemia patients. Deferasirox reduced iron overload in aplastic anemia patients enrolled in the EPIC (Evaluation of Patients
Externí odkaz:
https://doaj.org/article/be2d1486312041b2b09bae7c25444350
Publikováno v:
Journal of Power and Energy Engineering. :64-87
Combined heat and power (CHP) plants (co-generation plants) using biomass as fuel, can be an interesting alternative to the predominant electrical heating in Canada. The biomass-fueled boiler provides heat for the steam cycle which in turn generates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::598972faaf87fc2f2ce0292917c5185f
https://doi.org/10.4236/jpee.2020.83005
https://doi.org/10.4236/jpee.2020.83005
Autor:
Mohsen Saleh Elalfy, Ali El-Ali, John B. Porter, Ali T. Taher, Szu-Hee Lee, Amal El-Beshlawy, Pranee Sutcharitchan, Yesim Aydinok, Jackie Han
WOS: 000394910900011
PubMed ID: 27859648
BackgroundIn transfusion-dependent anaemias, while absolute serum ferritin levels broadly correlate with liver iron concentration (LIC), relationships between trends in these variables are unclear. T
PubMed ID: 27859648
BackgroundIn transfusion-dependent anaemias, while absolute serum ferritin levels broadly correlate with liver iron concentration (LIC), relationships between trends in these variables are unclear. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::842967a8c6bfd67c2096394ef673306a
https://hdl.handle.net/11454/32364
https://hdl.handle.net/11454/32364
Autor:
Shahina Daar, Kusai Al Zir, Mohsen Saleh Elalfy, Bernard Roubert, Amal El-Beshlawy, Ulrike Kriemler-Krahn, Dany Habr, Abdullah Al Jefri, Ali El-Ali, Ali T. Taher
Publikováno v:
European Journal of Haematology. 87:355-365
Following 1-yr deferasirox therapy in the ESCALATOR study, 57% of previously chelated patients with β-thalassaemia achieved treatment success (maintenance of or reduction in liver iron concentration (LIC) vs. baseline LIC). Seventy-eight per cent ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fda54fd0ff294435d400d5d0c71e00d3
https://doi.org/10.1111/j.1600-0609.2011.01662.x
https://doi.org/10.1111/j.1600-0609.2011.01662.x
Publikováno v:
Renewable Energy and Power Quality Journal. 1:273-276
In general, the Earth has two global movements that affect the reception of the solar energy to its surface: the rotation that it does once on itself per day and the yearly revolution that it does around the sun. The combination of these movements im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a300ac81e591dc9d1746a6ae978e25f
https://doi.org/10.24084/repqj06.281
https://doi.org/10.24084/repqj06.281
Autor:
Erhard Quebe-Fehling, James B. Bussel, Raymond Sm Wong, Abdulgabar Salama, Mansoor N. Saleh, Ali El-Ali, Balkis Meddeb, Abderrahim Khelif
Publikováno v:
Blood. 128:1368-1368
Introduction: ITP, characterized by a reduction in platelets leading to thrombocytopenia, which persists for >12 months is considered chronic (cITP). Eltrombopag is an oral thrombopoietin receptor agonist approved for treatment of patients with cITP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::081d13f82109dc9a077d6a7443471d30
https://doi.org/10.1182/blood.v128.22.1368.1368
https://doi.org/10.1182/blood.v128.22.1368.1368
Autor:
Antonio Piga, Immacolata Tartaglione, Jackie Han, Giuseppina Della Corte, Raffaella Origa, Gian Luca Forni, Chiara Castiglioni, Ali El-Ali
Publikováno v:
Blood. 128:2466-2466
Background: Patients (pts) with transfusion-dependent anemias now have longer life expectancy due to improved quality of care, in particular iron chelation therapy (ICT). Longer life and drug exposure increase the chance of complications, such as cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53d29332ca150de30d62b2d9a8285392
https://doi.org/10.1182/blood.v128.22.2466.2466
https://doi.org/10.1182/blood.v128.22.2466.2466
Autor:
Balkis Meddeb, James B. Bussel, Mansoor N. Saleh, Abderrahim Khelif, Abdulgabar Salama, Raymond Sm Wong, Erhard Quebe-Fehling, Ali El-Ali
Publikováno v:
Blood. 128:4930-4930
Introduction: Eltrombopag is an oral thrombopoietin receptor agonist, approved for the treatment of patients with cITP (persisting >12 months) aged ≥1 year, who are refractory to other treatments (eg corticosteroids, immunoglobulins). Pharmacokinet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be93d1d355401f4d60d8240f41dbf9f1
https://doi.org/10.1182/blood.v128.22.4930.4930
https://doi.org/10.1182/blood.v128.22.4930.4930
Autor:
Paul Burgess, Abdulgabar Salama, Victoria Barghout, James B. Bussel, Abderrahim Khelif, Ali El-Ali, Anuja Roy, Mei Sheng Duh, Mansoor N. Saleh, Kelly M. Grotzinger
Publikováno v:
Blood. 128:3742-3742
Background: EXTEND (June 2006 to July 2015) was an open-label, dose-adjustment extension study to evaluate the safety and efficacy of eltrombopag for the treatment of patients with chronic immune thrombocytopenia purpura (cITP) who had previously bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de435a98712278c93586272d22e7f597
https://doi.org/10.1182/blood.v128.22.3742.3742
https://doi.org/10.1182/blood.v128.22.3742.3742
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.